Brief: TetraLogic terminates public offering
06/05/2015 17:52
May 6 (Reuters) - TetraLogic Pharmaceuticals Corp TLOG.O : * Announces termination of public offering * Termination of public offering of 6.25 million shares of company's common stock at price to public of $4.00 per share * Offering was being conducted pursuant to shelf registration statement declared effective by SEC on January 15, 2015 * Source text for Eikon ID:nGNXVDMQWa * Further company coverage TLOG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Tetralogic Pharmaceuticals
See all newsNewscasts - Grieving father buries son killed by toxic cough syrup in India
Cellect: Soars on merger deal with Quoin Pharmaceuticals
Brief: Tetralogic announces pacts to restructure convertible debt
Brief: Tetralogic Pharmaceuticals says Pete Meyers resigned as CFO
Brief: TetraLogic Pharmaceuticals says birinapant shows no activity in randomized phase 2 mds study